Monique Levy has been appointed chief strategy officer of BlackThorn Therapeutics. Levy most recently worked at iCarbonX as global head of strategy and partnerships. Her experience also includes positions at PatientsLikeMe and Decision Resources Group. San Francisco-based BlackThorn is using artificial intelligence to help develop psychiatric drugs. In June, the company raised $76 million in Series B funding.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
